Glia Modulates Immune Responses in the Retina Through Distinct MHC Pathways. [PDF]
Intonti S+5 more
europepmc +1 more source
Single‐Cell Transcriptomic Analysis of the Immune Response to COVID‐19 and Tuberculosis Coinfection
Understanding the immunological basis for severe outcomes in COVID‐19/Tuberculosis coinfection is critical. Our single‐cell analysis identifies key drivers: profound lymphocyte loss through combined apoptosis and altered trafficking, excessive S100 protein‐mediated inflammation contributing to cytokine storms, and systemic immune dysfunction ...
Yi Wang+20 more
wiley +1 more source
Canine intestinal organoids as a platform for studying MHC class II expression in epithelial cells. [PDF]
Nakazawa M, Nagao I, Ambrosini YM.
europepmc +1 more source
ABSTRACT Multiple sclerosis (MS) is the most common non‐infectious inflammatory CNS disease, characterized by progressive neurodegeneration and focal demyelinated lesions. Traditionally considered an autoimmune disease, MS is driven by the immune system's attack on CNS myelin, resulting in cumulative disability.
Volker Siffrin
wiley +1 more source
Dexamethasone-Induced MerTK<sup>+/high</sup> M2c Macrophages Exhibit a Preference for Downregulated Gene Expression Profiles. [PDF]
Lee ZT+3 more
europepmc +1 more source
Progesterone receptor-dependent downregulation of MHC class I promotes tumor immune evasion and growth in breast cancer. [PDF]
Tinoco JC+20 more
europepmc +1 more source
Tumor-microenvironment and molecular biology of classic Hodgkin lymphoma in children, adolescents, and young adults. [PDF]
Aoki T+4 more
europepmc +1 more source
What's new? The remarkably poor prognosis of metastasized soft tissue sarcoma (STS) has motivated a search for novel biomarkers and therapeutic approaches. A promising candidate biomarker is H2A histone family member X (H2AX), a key player in DNA damage detection and repair pathways.
Adrian Georg Simon+14 more
wiley +1 more source
Predicting reverse-bound peptide conformations in MHC Class II with PANDORA. [PDF]
Rademaker DT+5 more
europepmc +1 more source
What's new? Despite advances, the efficacy of current immune checkpoint inhibitor therapies remains suboptimal in non‐small cell lung cancer due to the immunosuppressive tumor microenvironment. Here, ILT5 was found to be highly expressed in tumor‐associated macrophages from non‐small cell lung cancer tissues and associated with poor patient survival ...
Huijun Xu+10 more
wiley +1 more source